Therapeutic noninvasive brain stimulation in Alzheimer's disease

By Irene Gonsalvez, Roey Baror, Peter Fried, Emilio Santarnecchi and Alvaro Pascual-Leone - Current Alzheimer Research 2017.


Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer disease

By Jean Paul Nguyen, Alicia Suarez, Gilles Kemoun, Michel Meignier, Estelle Le Saout , Philippe Damier, Julien Nizard, Jean-Pascal Lefaucheur – 3.1.2017 (English & French)


Journal of Clinical Neurology

April 2016, Volume 12, pp 57-64.


Alzheimer's & Dementia: The Journal of the Alzheimer's Association

July 2013, Volume 9, Issue 4, Supplement , Page P664.


Journal of Neural Transmission

May 2013, Volume 120, Issue 5, pp 813-819.


Journal of Neural Transmission

March 2011, Volume 118, Issue 3, pp 463-471.

neuroAD is an investigational device currently not commercially available in the United States.
neuroAD is CE-cleared and commercially available for the treatment of mild to moderate Alzheimer’s Disease in Europe.

® August 3, 2017 Neuronix | All rights reserved.
a site by razgroup